摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基喹啉-3-甲腈 | 72248-92-1

中文名称
2-甲基喹啉-3-甲腈
中文别名
——
英文名称
2-methylquinoline-3-carbonitrile
英文别名
2-Methyl-3-cyanoquinoline;3-cyano-2-methylquinoline;2-methyl-quinoline-3-carbonitrile;2-Methyl-chinolin-3-carbonitril
2-甲基喹啉-3-甲腈化学式
CAS
72248-92-1
化学式
C11H8N2
mdl
MFCD18803382
分子量
168.198
InChiKey
FYIDOXAVHGPMLM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    131 °C
  • 沸点:
    324.8±22.0 °C(Predicted)
  • 密度:
    1.17±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    36.7
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H312,H315,H319,H332,H335

SDS

SDS:ef35cbd5aa393066bbfb800de05de0d2
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOPYRANOSYL-SUBSTITUTED BENZENE DERIVATIVE
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP3939577A1
    公开(公告)日:2022-01-19
    The invention relates to a pharmaceutical composition according to the claim 1 comprising a glucopyranosyl-substituted benzene derivative in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
    该发明涉及根据权利要求1的药物组合物,包括一种葡萄糖吡喃基取代苯衍生物与一种适用于治疗或预防从以下选定的一种或多种疾病的DPP IV抑制剂的组合物,所述疾病包括1型糖尿病、2型糖尿病、糖耐量受损和高血糖。此外,本发明涉及预防或治疗代谢紊乱及相关疾病的方法。
  • 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same
    申请人:Green Jeffrey Neal
    公开号:US20060264460A1
    公开(公告)日:2006-11-23
    The present invention provides compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , m and n are defined as described herein. The invention also provides methods of making the compounds of formula (I), and methods of treating inflammatory diseases, such as rheumatoid arthritis, in a mammal comprising administering a therapeutically effective amount of a compound of formula (I) to the mammal.
    本发明提供了如下式(I)的化合物及其药用可接受的盐,其中R1、R2、R3、R4、R5、R6、R7、R8、m和n的定义如本文所述。该发明还提供了制备如式(I)化合物的方法,以及治疗炎症性疾病(如类风湿性关节炎)的方法,包括向哺乳动物施用如式(I)化合物的治疗有效量。
  • 8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition
    申请人:Himmelsbach Frank
    公开号:US20050187227A1
    公开(公告)日:2005-08-25
    The present invention relates to substituted xanthines of general formula wherein R 1 and R 2 are defined as in the claims, the tautomers, the stereoisomers, the mixtures thereof, and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及一般式中的取代黄嘌呤,其中R1和R2如索赔中定义,其互变异构体、立体异构体、混合物以及盐具有有价值的药理特性,特别是对酶二肽基肽酶-IV(DPP-IV)的抑制作用。
  • Ru(III)-catalyzed construction of variously substituted quinolines from 2-aminoaromatic aldehydes (ketones) and isoxazoles: Isoxazoles as cyclization reagent and cyano sources
    作者:Di Hu、Chao Pi、Wei Hu、Xiliang Han、Yangjie Wu、Xiuling Cui
    DOI:10.1016/j.cclet.2021.12.072
    日期:2022.8
    N-O bond cleavage and fragmentation. Variously substituted (especially 6- or 7-substituted) quinolines could be easily afforded. This procedure features wide functional group compatibility, efficiency and avoiding toxic cyano source. Meanwhile, this protocol could be successfully applied to scale-up synthesis. Further chemical transformations of 3-cyanoquinoline could give some valuable skeletons, demonstrating
    开发了 Ru(Ⅲ) 催化的 2-氨基芳香醛(酮)和异恶唑的环化反应,得到多种 3-氰基喹啉。值得注意的是,异恶唑通过NO 键断裂和断裂充当环化试剂和无毒氰基源。可以很容易地提供各种取代(尤其是 6 或 7 取代)的喹啉。该程序具有广泛的官能团兼容性、效率和避免有毒氰基源。同时,该协议可以成功地应用于放大合成。3-氰基喹啉的进一步化学转化可以产生一些有价值的骨架,证明其在合成应用中的潜力
  • 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
    申请人:Himmelsbach Frank
    公开号:US20050234108A1
    公开(公告)日:2005-10-20
    The present invention relates to substituted xanthines of general formula wherein R is defined as in claim 1 , the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    本发明涉及通式所示的取代黄嘌呤,其中R如权利要求书中所定义,其互变体、立体异构体、其混合物和盐具有有价值的药理特性,特别是对酶二肽基肽酶-IV(DPP-IV)活性的抑制作用。
查看更多